Table 3.

LPL mRNA concentration during acute and chronic inactivity

	Soleus (% of control)	Rectus femoris (% of control)
Ambulatory control (n = 4–12)‡	100 ± 6	100 ± 4
12 h HU (n = 12)	91 ± 6	87 ± 14
11 days of 10 h day−1 HU (n = 8)	69 ± 9	—
7 days of 24 h day−1 HU (n = 4)	27 ± 8*†	101 ± 9

^‡HU groups were compared with respective controls studied at the same time (n = 12 for 12 h and n = 4–8 for 7–11 days).

^*P < 0.01 between HU and control,

^†P < 0.01 between intermittent and continuous HU.